glp-1 agonist definition Glucagon-like peptide-1 Frontiers | The agony and
Description
This helps them make the right diagnosis and choose the best treatment
doi: 10.1038/nn1452, 155 WaddenT
In fact, large cohort-based studies have implicated sulfonylureas to potential harmful cardiovascular outcomes in patients with type 2 diabetes [3-5]
[DOI] [PubMed] [Google Scholar] 100.Wharton S., Blevins T., Connery L., Rosenstock J., Raha S., Liu R., Ma X., Mather K.J., Haupt A., Robins D., et al
In Proceedings of the Diabetes Care
Krisanapan P, Sanpawithayakul K, Pattharanitima P, Thongprayoon C, Miao J, Mao MA, et al
